Official UK procurement notice
NHS National Framework for Ruxolitinib
Authority: NHS England (Central government)
What is being bought
Published requirement descriptionProject title: NHS National Framework for Ruxolitinib
Offer reference number: CM/TNS/26/5755
Period of framework: 01 April 2028 to 31 March 2029 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
CPV: Pharmaceutical products
How this framework works
From the published notice- Framework period
- 1 yr · up to 3 yrs from 1 Apr 2028
The lotProcurement structure
single lot · no lot value publishedLot #1PlannedRenewal
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- “NHS National Framework for Ruxolitinib” is a framework: the contest is a place on its panel, not a single contract.
Pipeline intelligence · planning stage: how this market runs before the tender is published
How NHS England buys Pharmaceutical products (CPV 3360), and who usually turns up
NHS England’s published record next to the market for the same work. Compared with other frameworks and DPS only. Whole-market view: Pharmaceutical products (CPV 3360) →
How the contest usually goes
Winner shares use published awards; bid and price charts use contested lots.
i
How often small and medium firms win.
Share of awards where the winner’s size is known.
The counts under this question show how many awards have a known supplier size.
Small firms have won here. Neither number says whether you qualify; it describes who has been winning.
i
How often local firms win similar work.
Winners with a registered address in the delivery region, out of awards with a known address.
Local means the winner is registered in the region where that award was delivered.
A local branch does not count if the registered address is elsewhere.
No winner locations published for this authority. Local means a registered address in the region where that award was delivered.
i
How long buyers here take to decide after bids close.
Middle value in days from the bid deadline to the award date, on competitions that published both.
Only decided tenders count, so slow ones still waiting are not in.
Half of these awards have an award date within 27 days of the bid deadline.
i
How often work is awarded with no recorded rival.
Direct awards and tenders where every published lot count shows one bid.
The market share is a minimum: some awards have no bid count.
Thin markets produce this too; it is not proof of a tailored specification.
Awards are recorded, but published direct routes and bid counts do not establish this buyer’s share.
How many bids did past lots attract?
i
How many bids past lots received.
Each colour is a bid-count range. Only competed lots with a published count are included.
Past bids do not predict this tender.
1 bid15% / 20%
2–323% / 23%
4–616% / 28%
7+46% / 28%
How did awards compare with estimates?
i
Where winning prices landed against estimates.
Each colour shows awards below, close to or above the published estimate, one lot at a time.
On a framework or DPS, prices are agreed when work is called off.
Past prices are a guide, not a bid price.
Not comparable on a framework or DPS: the price is set later, on each call-off.
Assess each lot i
What past awards tell you about each lot.
See the forecast, this buyer’s earlier suppliers and firms with relevant wins.
No supplier is confirmed as a bidder.
i
What past awards tell you about each lot.
See the forecast, this buyer’s earlier suppliers and firms with relevant wins.
No supplier is confirmed as a bidder.
Open a lot for its forecast, this buyer’s previous supplier and possible competitors, from published award history, not a bid list
Our matching links this notice to “NHS Framework Agreement for Branded Medicines - National Tender” of this authority, but none of the 11 panel members sit in a category matching this notice.
Lot #1CPV 3360Published estimate£106m
i
How many bids this lot may attract.
The forecast uses similar past competitions. The bar shows either that forecast or past bid counts; the line below says which.
Each lot shows its own forecast based on its own category; forecasts for different lots of the same notice are not comparative. The bar shows 95 past lots.
A forecast, not a list of bidders.
1 bid20%
2–323%
4–628%
7+28%
i
Where the award price may land.
The forecast uses similar awards and the buyer’s estimate. The band covers the middle half of likely prices.
No comparable awards for this lot yet.
A statistical guide from past awards, not a price to bid.
Who has supplied this buyer on similar work? i
Who has done similar work for this buyer.
Past contracts are matched by buyer, title and type of work.
A past supplier may not bid again.
i
Who has done similar work for this buyer.
Past contracts are matched by buyer, title and type of work.
A past supplier may not bid again.
| Supplier | This buyer’s earlier contract | Lot | Award value | Why listed |
|---|---|---|---|---|
| NOVARTIS PHARMACEUTICALS UK LIMITEDEarlier contract | NHS National Framework for Transition products (Axitinib and Eltrombopag)started Sept 2025 | — | — | Matched as the earlier contract |
| Ipsen LtdEarlier contract | NHS Framework Agreement for Branded Medicines – Nationalended Apr 2023 | — | — | Matched as the earlier contract |
| Ridge Pharma LimitedEarlier contract | NHS Framework Agreement for Branded Medicines – Nationalended Apr 2023 | — | — | Matched as the earlier contract |
| Biocon Pharma UK LtdEarlier contract | NHS National Framework for Transition products commencing 1 February 2025ended May 2026 | — | — | Matched as the earlier contract |
| Aspire Pharma LtdEarlier contract | NHS National Framework for Transition products commencing 1 May 2024ended Sept 2025 | Dimethyl fumarate, Teriflunomide, Trabectedin | — | Matched as the earlier contract |
Who could compete for this lot? i
Who could compete for this lot?
Firms with relevant past wins. On a framework, we show firms on that agreement.
None is confirmed as a bidder.
i
Who could compete for this lot?
Firms with relevant past wins. On a framework, we show firms on that agreement.
None is confirmed as a bidder.
Candidate suppliers for this notice have not been worked out yet, so this is not a verdict that nobody fits.
About this data
- Source. Official UK public procurement notices (Find a Tender), reused under the Open Government Licence v3.0. New notices arrive through the day; the figures are rebuilt nightly.
- Two views, kept apart. The authority’s own track record and the wider market for the same kind of work sit side by side and are never mixed. Where the local picture is too thin, a figure widens to a broader market and says which one it used.
- Forecasts are labelled. The price forecast and its range, possible competitors and the earlier-work matches are our estimates from past awards: not published facts, not win chances and not price advice. Official notices do not say who is bidding.
- Every figure shows what it rests on. Not every notice publishes a bid count, a value or a delivery region, so each figure carries the number of records behind it, and one built on few records is marked as such. The on a figure explains it; the counting rules are in the methodology. Spotted something wrong? Tell us.
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Procurement category
- Goods
- Notice status
- Planned procurement
- Procurement threshold
- Above threshold (FTS publication)
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 23 Apr 2026, 08:15 BST
- Last source update
- 2 Sept 2026, 15:14 BST
- Authority reference
CM/TNS/26/5755- FTS notice number
2026/S 000-083136- Latest notice
- Preliminary market engagement notice (UK2)
- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-06891cFind a Tender
How it was run
Official notice- Appointment period ends
- —
Timeline
23 Apr 2026 → 1 Apr 2028 · 5 dates- Planning notice published186 days ago23 Apr 2026, 08:15 BST
- Market engagement163 days ago15 May 2026, 23:59 BST
NHS England is seeking to engage with current or potential new suppliers that are planning to launch any of the molecule(s) that will be covered by this procurement. Interested suppliers will be invited to a virtual preliminary market engagement meeting.
The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's.
Please contact [email protected] or [email protected] to register your interest in tendering for this framework.
- Latest notice published53 days ago2 Sept 2026, 15:14 BST
- Today26 Oct 2026
- Tender notice expectedin 248 days30 Jun 2027, 23:59 BST
- Contract starts1 Apr 2028, 00:00 BST
Notice history
4 events · 3 releases on Find a Tender · since 23 Apr 2026- Pipeline notice published23 Apr 2026, 08:15 BSTUK1
- Preliminary market engagement notice published30 Apr 2026, 18:10 BSTUK2
- Published value updated to £105,900,00030 Apr 2026, 18:10 BSTwas £35,300,000
- Preliminary market engagement notice published2 Sept 2026, 15:14 BSTUK2
Published amendments (1)
Revised timelines as follows: - Contract Start Date changed from 01/11/2026 to 01/04/2028 - Contract End Date changed from 31/10/2027 to 31/03/2029 - Extension End Date changed from 31/10/2029 to 31/03/2031 - Estimated Publication Date changed from 01/07/2026 to 30/06/2027 Period of Framework in Description changed from: '01 November 2026 to 31 October 2027 with an option or options to extend (at …
Commercial outcome & contract awards
Pipeline notice- Awards (0)
- No award published
- Contracts (0)
- No contract published
- Bid statistics
- No aggregate bid statistics published
Contracting authority & participating public bodies
Official documents & specifications (3)
Official links; attachments are not copiedNotices published for this procedure
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender
- Pipeline notice Pipeline notice on Find a Tender